{"entity":{"type":"insider","cik":"0001379033","url":"/insider/0001379033","json_url":"/insider/0001379033.json","name":"Berman Michael A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":4,"first":"2007-05-11","last":"2008-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Berman Michael A","source":"filing","n_filings":4,"first_seen":"2007-05-11","last_seen":"2008-05-19"}],"transactions":[{"id":3940168,"accession":"0001209191-08-031362","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-08-031362","line_url":"/filing/0001209191-08-031362","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":6.322,"price_display":"6.32","price_state":"stated","total_value":56898.0,"total_display":"56,898.00","total_whole":"56,898","shares_owned_after":23300.0,"shares_owned_after_display":"23,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-16","filed_date":"2008-05-19","scope":"insider","n_lines":5},{"id":3940157,"accession":"0001209191-08-031362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-031362","line_url":"/filing/0001209191-08-031362","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":6.110909090909091,"price_display":"6.11","price_state":"stated","total_value":6722.0,"total_display":"6,722.00","total_whole":"6,722","shares_owned_after":19500.0,"shares_owned_after_display":"19,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-15","filed_date":"2008-05-19","scope":"insider","n_lines":2},{"id":3180509,"accession":"0001209191-08-019356","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-08-019356","line_url":"/filing/0001209191-08-019356","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.374493,"price_display":"5.37","price_state":"stated","total_value":53744.93,"total_display":"53,744.93","total_whole":"53,745","shares_owned_after":18500.0,"shares_owned_after_display":"18,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-17","filed_date":"2008-03-19","scope":"insider","n_lines":11},{"id":9264970,"accession":"0001209191-08-020323","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-020323","line_url":"/filing/0001209191-08-020323#line-3","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":12.1673,"price_display":"12.17","price_state":"stated","total_value":60836.5,"total_display":"60,836.50","total_whole":"60,837","shares_owned_after":8500.0,"shares_owned_after_display":"8,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-15","filed_date":"2008-03-26","scope":"insider"},{"id":7696992,"accession":"0001209191-07-029756","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-029756","line_url":"/filing/0001209191-07-029756#line-3","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":12.1673,"price_display":"12.17","price_state":"stated","total_value":60836.5,"total_display":"60,836.50","total_whole":"60,837","shares_owned_after":33500.0,"shares_owned_after_display":"33,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-15","filed_date":"2007-05-11","scope":"insider"},{"id":9264974,"accession":"0001209191-08-020323","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-020323","line_url":"/filing/0001209191-08-020323#line-2","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":31250.0,"total_display":"31,250.00","total_whole":"31,250","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-14","filed_date":"2008-03-26","scope":"insider"},{"id":7696990,"accession":"0001209191-07-029756","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-029756","line_url":"/filing/0001209191-07-029756#line-2","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":31250.0,"total_display":"31,250.00","total_whole":"31,250","shares_owned_after":28500.0,"shares_owned_after_display":"28,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-14","filed_date":"2007-05-11","scope":"insider"},{"id":9264973,"accession":"0001209191-08-020323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-020323","line_url":"/filing/0001209191-08-020323","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":9.48375,"price_display":"9.48","price_state":"stated","total_value":15174.0,"total_display":"15,174.00","total_whole":"15,174","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-01","filed_date":"2008-03-26","scope":"insider","n_lines":3},{"id":7696989,"accession":"0001209191-07-029756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-029756","line_url":"/filing/0001209191-07-029756#line-1","is_derivative":false,"issuer_cik":"0001333248","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001333248","owner_cik":"0001379033","owner_name":"Berman Michael A","owner_display_name":"Berman Michael A","owner_url":"/insider/0001379033","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.45,"price_display":"9.45","price_state":"stated","total_value":9450.0,"total_display":"9,450.00","total_whole":"9,450","shares_owned_after":26000.0,"shares_owned_after_display":"26,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-01","filed_date":"2007-05-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":26,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Director","n_filings":4,"first_seen":"2007-05-11","last_seen":"2008-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001379033","retrieved_at":"2026-08-26T05:00:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}